Sentinelle to license Medipatterns breast CAD technology

Justine Varieur Cadet | | Health Exec | Precision Medicine
Medical software developer Medipattern and Sentinelle Medical, a manufacturer of MRI coils and advanced visualization software, are entering a technology access and distribution agreement.

The Toronto-based Medipattern developed breast ultrasound computer-aided detection (CAD) breast lesion MRI morphological analysis technology. Under the agreement, the Toronto-based Sentinelle would gain exclusive license to Medipattern's breast MRI morphological analysis technology.

Morphological analysis, lesion kinetics, diffusion contrast coupled with breast MRI images produced by Sentinelle's line of MRI coils could assist in lesion detection and differentiation, according to Cameron Piron, CEO of Sentinelle. "Partnering with Medipattern allows us to launch a next-generation platform that will utilize these developments,” he added.

Justine Varieur Cadet

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."